
|Articles|November 1, 2002
Stockholders to vote: Investments breathe life into ISTA Pharmaceuticals
Irvine, CA-ISTA Pharmaceuticals Inc. has secured $44 million in financing, including a $4 million bridge loan, to complete development work on late-stage ophthalmic products in the company's clinical pipeline.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Lesion growth rate reduction tops retina specialists' geographic atrophy treatment priorities
3
Detecting peripheral retinal lesions in children with myopia
4
Personalized Treatment with Faricimab in Retinal Vascular Diseases
5


























